New Patient Offer
(Value of $150)
New cash patients only.
X-Rays are not included.
Complete the form below to take advantage of this offer!
Offer Expires 12/11/2019
Oral Cancer Screening - OraRisk HPV
OraRisk® HPV is a salivary DNA test that determines who is at increased risk for HPV-related oral cancers. It is a non-invasive, easy-to-use screening tool to identify the type(s) of HPV, a mucosal viral infection that could potentially lead to oral cancer. OraRisk® HPV enables the clinician to establish increased risk for oral cancer and determine appropriate referral and monitoring conditions.
It is a well-known fact that the Human Papillomavirus (HPV) is the cause of cervical cancer. Young women can now be vaccinated with Gardasil® to prevent them from ever having cervical cancer. Out of that research, we have determined people who test positive for the four high risk strains of oral HPV have a much greater risk developing cancer as a result of having this virus in their oropharnyx (mouth/throat).
Recent research indicates that patients that have had a history of squamous cell carcinoma are at a dramatically increased risk of having HPV (Human Papillomavirus) in their oropharynx. This increases their risk of having a malignancy in the oropharynx.
"It is estimated that more than 1,700 new cases of HPV-associated head and neck cancers are diagnosed in women and nearly 5,700 are diagnosed in men each year in the United States.* These numbers are based on cancers in specific areas of the head and neck (oral cavity and oropharynx) and do not include cancers in all areas of the head and neck. Afro-American people get these cancers more often than people of other races and ethnicities and Non-Hispanics and men get these cancers more often than Hispanics and women."
According to the latest statement released from the CDC.
Oral HPV has made its presence in dentistry at a surprising high incidence. I have had several of my own patients present with this virus and have found a quick, simple and non-invasive salivary test in order to diagnose if the HPV virus is present. The test is called OraRISK® HPV from Oral DNA Labs, a division of Quest Diagnostics.
OraRISK® HPV identifies the type(s) of oral HPV present, as well as the associated risk profile for each type of HPV detected. The test also lists the HPV types as high, low or unknown risk based on the virus's association with malignant changes in HPV-infected cells. I utilize this test to establish the patient's increased risk for oral cancer and determine appropriate referral and monitoring conditions.
For more information, please click on the external link to
Oral DNA Labs
Cleaning and Prevention Procedures:
Dental services provided by Dr. Behn: